MeiraGTx Holdings (MGTX) Preferred Dividend Payments (2017 - 2018)
MeiraGTx Holdings (MGTX) posted Preferred Dividend Payments of $1.1 million for Q2 2018, up 71.77% on a QoQ basis from $664718.0 in Q1 2018, and up 3655.78% year-over-year from $30401.0 in Q2 2017.
MeiraGTx Holdings (MGTX) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
MeiraGTx Holdings' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $1.1 million for Q2 2018.
- Quarterly Preferred Dividend Payments rose 3655.78% year-over-year to $1.1 million in Q2 2018, while the trailing twelve-month figure through Dec 2018 was $1.8 million (changed N/A YoY) and the FY2018 annual result came in at $1.8 million, up 123.87% from the prior year.
- Preferred Dividend Payments was $1.1 million for Q2 2018 at MeiraGTx Holdings, up from $664718.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $1.1 million in Q2 2018 and bottomed at $30401.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 1.14 Mn |
| Mar 31, 2018 | 664,718.00 |
| Dec 31, 2017 | 562,043.00 |
| Sep 30, 2017 | 191,758.00 |
| Jun 30, 2017 | 30,401.00 |